GlassScriptPhysician profile
Quinton T Young
NPI 1306148879
$877.70
in general payments reported to CMS, 2019-2025
21 companies · $309 in 2025
The $309 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $66.90 · 2021: $56.23 · 2022: $19.02 · 2023: $50.84 · 2024: $101 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $95.37 | 2019-2024 | |
| Sanofi Pasteur INC. | $94.73 | 2021-2025 | |
| Pfizer INC. | $73.07 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $72.29 | 2025 | Qelbree |
| Collegium Pharmaceutical, INC. | $67.43 | 2025 | Jornay Pm |
| Tris Pharma INC | $63.03 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.82 | 2019 | |
| Merck Sharp & Dohme LLC | $55.02 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi-Aventis U.S. LLC | $41.08 | 2025 | |
| Genzyme Corporation | $34.82 | 2021 | |
| Cranial Technologies, INC | $33.16 | 2023 | Doc Band |
| Dermira, INC. | $31.90 | 2019 | |
| Glaxosmithkline, LLC. | $25.99 | 2019 | |
| Lnhc, INC | $18.92 | 2025 | Zelsuvmi |
| Kowa Pharmaceuticals America, INC. | $18.49 | 2025 | Zoryve |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $17.88 | 2020 | |
| Amgen INC. | $16.54 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $15.69 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.33 | 2020 | |
| Allergan, INC. | $12.74 | 2019 | |
| Corium, LLC | $11.40 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quinton Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.